Get company alerts
Menu
Company journeys ↗
← All companies

Healthcare / COMPANY INTELLIGENCE

Sword Health

Technology-supported care with clinical oversight, including services focused on pain and recovery.

01 / THE BUSINESS

How Sword Health creates value.

Technology-supported care with clinical oversight, including services focused on pain and recovery. The research questions below focus on what would need to be true for adoption to translate into durable economics.

SectorHealthcare
Research coverageBusiness & sources
Research checkedSep 20, 2026

03 / CAPITAL & OWNERSHIP

Follow the financing.

Selected disclosed events, newest first. Announcement values describe that transaction and date; they are not current share prices. Debt, equity and secondary transactions are identified separately.

A financing figure is not established here.

Use the original company sources below to check new announcements. We have not substituted an estimate for a disclosed round.

05 / EDITORIAL ANALYSIS

The opportunity. The open questions.

Our interpretation of the business model and cited sources, not a valuation or a recommendation.

What could work

The case to investigate

  • Evidence of better access or less administrative work may support payer and employer adoption.
What could go wrong

Pressure-test the thesis

  • Clinical errors, privacy failures and reimbursement changes can disrupt the business.
  • Reported savings may not reproduce across patient populations.

What to watch next

01

What evidence supports durable outcomes and savings after adjusting for patient selection?

02

What do the latest original disclosures establish about revenue quality, ownership rights and financing needs?

YOUR RESEARCH WORKSPACE

Keep the questions that matter.

Use this checklist to record what you have investigated. Your notes stay in this browser.

06 / RESEARCH TRAIL

Go straight to the source.

Research checked Sep 20, 2026. Selected public disclosures, not a complete capitalization table or securities-filing search. Missing information is left unconfirmed. No investment availability or IPO date is implied.